The companies will look to combine their respective strengths with BioAmber focusing on the production of bio-chemicals and Mitsu distributing them. The partners also plan to build two additional facilities at the location, bringing the total processing capacity of succinic acid to 35,000 metric tonnes and 23,000 metric tonnes for butanediol. BioAmber will be the majority shareholder in the Canadian plant.
The partnership also includes a strategy to build an additional manufacturing facility in Thailand scheduled to enter operation in 2014.
Masanori Ikebe, general manager of Mitsui’s specialty chemicals division, said, ‘Our goal is to play a leading role in the growth of renewable chemicals, as evidenced by our recent joint ventures with BioAmber in North America for biosuccinic acid and The Dow Chemical Company in Brazil for biochemicals. We believe that biosuccinic acid and bio‐BDO will experience rapid growth over the next decade, and BioAmber’s technology leadership is an excellent fit with Mitsui’s strength across the supply chain.’
Jean‐Francois Huc, CEO of BioAmber, added, ‘BioAmber’s partnership with Mitsui & Co is a strong endorsement of our technology platform. Mitsui is an ideal partner thanks to its long‐term commitment to renewable chemistry, its extensive reach into chemical markets and its strategic access to sustainable feedstocks. Mitsui also has the financial strength to support our expansion and help us compete internationally.’
Copyright © 2011 NewNet
You must be logged in to post a comment.